Vident Advisory’s Takeda Pharmaceutical TAK Stock Holding History

Vident Advisory's TAK Position: Q2 2026 in Review

Vident Advisory increased its Takeda Pharmaceutical (TAK) stake by 92% in Q2 2026, buying an estimated $1.14M and bringing the position to 143,921 shares worth $2.31M. The position accounts for 0.02% of the portfolio, ranked #641.

Vident Advisory first reported a position in TAK in Q3 2023 and has held it in 11 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

• Vident Advisory held 143,921 shares of Takeda Pharmaceutical worth $2.31M as of Q2 2026.
• Vident Advisory bought 68,885 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.14M.
• Takeda Pharmaceutical made up 0.02% of Vident Advisory's portfolio in Q2 2026, its #641 holding.
• Vident Advisory first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 11 quarters since.
• 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.